Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease
Top Cited Papers
- 15 January 2008
- journal article
- review article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 75 (2), 346-359
- https://doi.org/10.1016/j.bcp.2007.07.004
Abstract
No abstract availableKeywords
This publication has 118 references indexed in Scilit:
- Role of Matrix Metalloproteinases in Early Hypertensive Vascular RemodelingHypertension, 2007
- Matrix metalloproteinase 2–induced venous dilation via hyperpolarization and activation of K+ channels: Relevance to varicose vein formationJournal of Vascular Surgery, 2007
- Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood–brain barrier opening in rodents: Differences in response based on strains and solventsBrain Research, 2007
- Key Role of the NO-Pathway and Matrix Metalloprotease-9 in High Blood Flow-Induced Remodeling of Rat Resistance ArteriesArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- RETRACTED: Expression of matrix metalloproteinase-26 (MMP-26) mRNA in mouse uterus during the estrous cycle and early pregnancyLife Sciences, 2005
- Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatmentJournal of Human Hypertension, 2003
- Post-translational Proteolytic Processing of Procollagen C-terminal Proteinase Enhancer Releases a Metalloproteinase InhibitorOnline Journal of Public Health Informatics, 2000
- Small artery structure in hypertension. Dual processes of remodeling and growth.Hypertension, 1993
- A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursorNature, 1993
- Preferential binding of collagenase to α2‐macroglobulin in the presence of the tissue inhibitor of metalloproteinasesFEBS Letters, 1986